<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism (IGM) are associated with an increased <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) risk </plain></SENT>
<SENT sid="1" pm="."><plain>Increased left ventricular mass (LVM) is thought to increase <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk through several unfavorable cardiac changes </plain></SENT>
<SENT sid="2" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and IGM are associated with increased LVM, but the underlying mechanism is unclear </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the association between <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTS</z:e>) and LVM and explored whether any such association could be mediated through increased arterial stiffness, impaired endothelial function, or the presence of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESEARCH DESIGN AND METHODS: We used ultrasound to measure LVM, carotid and femoral stiffness, carotid-femoral transit time, and flow-mediated vasodilation (FMD) and tonometry to estimate compliance and augmentation index </plain></SENT>
<SENT sid="5" pm="."><plain>The study population (n = 780) consisted of 287 individuals with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism (NGM), 179 with IGM, and 314 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and the mean age was 68.4 years </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In women, after adjusting for age, height, BMI, and mean arterial pressure, LVM increased significantly with deteriorating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTS</z:e> (LVM 157 g in NGM, 155 g in IGM, and 169 g in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>; P for trend &lt;0.018) </plain></SENT>
<SENT sid="7" pm="."><plain>Additional adjustment for arterial stiffness, FMD, or the presence of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> did not materially alter the results, even though these variables were significantly associated with both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTS</z:e> and LVM </plain></SENT>
<SENT sid="8" pm="."><plain>Indexes of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>/-insulinemia or <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> explained at most 7% of the association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTS</z:e> and LVM </plain></SENT>
<SENT sid="9" pm="."><plain>In men, no statistically significant associations were observed </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our data expand the conceptual view of the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTS</z:e>-related changes in LVM because we show that the increase in LVM in women is independent of increased arterial stiffness, impaired FMD, or the presence of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, we show that this increase in LVM is only minimally explained by indexes of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>/-insulinemia or <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Our data may, in part, explain the increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk seen in women with deteriorating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTS</z:e> </plain></SENT>
</text></document>